P3 Prostate Cancer Forum: 2024

Session 1 - Prostate Cancer Screening: Current Perspectives on effective management

P3 background - Article

In session 1, explore valuable insights on prostate cancer screening. Our expert panel delve into the changing dynamics within screening in the UK and the EU, including the latest on the TRANSFORM study. 

The session is been split into three sections:

Prostate Cancer Screening: Prostate Cancer UK’s Position, plans and priorities - Dr Matthew Hobbs

Prostate Cancer Screening – a European Model – Prof Phil Cornford

Prostate Cancer Screening in the UK – are we ready for a change? – Professor Caroline Moore


Prostate Cancer Screening: Prostate Cancer UK’s Position, plans and priorities

Dr Matthew Hobbs

Meeting Summary Downloadable

Download the summary below for the key takeaways from this meeting.

Speakers
    • Caroline Moore
      Professor Caroline Moore
      Professor of Urology at University College London in the Department of Targeted Intervention
    • Phillip Cornford
      Professor Philip Cornford
      Honorary Associate Professor, Liverpool University Hospitals NHS Foundation Trust, Chair of EAU Prostate Cancer Guidelines Panel
    • Matthew Hobbs
      Dr Matthew Hobbs
      Director of Research, Prostate Cancer UK
Session 2 - Decoding mHSPC: Unravelling the complexities

In session 2,  our experts share their insights on optimising treatment in mHSPC, delving specifically into triple therapy: data, case studies and holistic patient management. 

Register your interest to P3 2025 now!
Register your interest in attending the P3 2025 meeting
PP-NUB-GB-1919, October 2024
Session 2: Decoding mHSPC: Unravelling the complexities
Our experts share their insights on optimising treatment in mHSPC, delving specifically into triple therapy.
PP-NUB-GB-2016, January 2025

PP-NUB-GB-2013 | January 2025